Racura Executive Director on Disrupt Radio
Racura Executive Director on Disrupt Radio
Racura Oncology Executive Director Dr Peter Smith joined Disrupt Radio to discuss building biotech businesses in Australia, what to look out for when investing in biotech businesses, and why Racura’s lead drug bisantrene is...
What’s In Store For 2024: Racura Oncology
What’s In Store For 2024: Racura Oncology
2024 Preview: Racura Oncology (ASX:RAC) from Stockhead on Vimeo. Stockhead’s Ashtyn Hiron sits down with Racura Oncology (ASX:RAC) CEO Daniel Tillett to close the books on 2023 and gain a sneak peek into what’s around the corner. The clinical stage...